Janet Sultana

3.5k total citations · 2 hit papers
77 papers, 2.1k citations indexed

About

Janet Sultana is a scholar working on Economics and Econometrics, Geriatrics and Gerontology and Toxicology. According to data from OpenAlex, Janet Sultana has authored 77 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Economics and Econometrics, 10 papers in Geriatrics and Gerontology and 10 papers in Toxicology. Recurrent topics in Janet Sultana's work include Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Pharmaceutical Economics and Policy (9 papers). Janet Sultana is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (13 papers), Pharmacovigilance and Adverse Drug Reactions (10 papers) and Pharmaceutical Economics and Policy (9 papers). Janet Sultana collaborates with scholars based in Italy, United Kingdom and Malta. Janet Sultana's co-authors include Gianluca Trifirò, Paola Maria Cutroneo, Andrea Fontana, Francesco Salvo, Salvatore Crisafulli, Edoardo Spina, Gianluca Trifirò, Sonia Messina, Ylenia Ingrasciotta and Francesco Giorgianni and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Scientific Reports.

In The Last Decade

Janet Sultana

73 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Clinical and economic burden of adverse drug reactions

2013 377 citations Janet Sultana, Paola Maria Cutroneo et al. profile →
Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis

2020 254 citations Janet Sultana, Andrea Fontana et al. Orphanet Journal of Rare Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Janet Sultana Italy	24	449	376	294	265	257	77	2.1k
Emanuel Raschi Italy	34	636 1.4×	608 1.6×	143 0.5×	247 0.9×	214 0.8×	169	4.1k
Loes E. Visser Netherlands	36	913 2.0×	247 0.7×	336 1.1×	418 1.6×	215 0.8×	124	4.3k
Sabine M. J. M. Straus Netherlands	31	764 1.7×	616 1.6×	144 0.5×	450 1.7×	558 2.2×	108	3.7k
Hubert G.M. Leufkens Netherlands	23	325 0.7×	879 2.3×	375 1.3×	398 1.5×	480 1.9×	62	3.0k
François Montastruc France	29	167 0.4×	406 1.1×	302 1.0×	261 1.0×	147 0.6×	145	2.3k
David J. Graham United States	33	654 1.5×	396 1.1×	168 0.6×	354 1.3×	585 2.3×	115	5.6k
Diane K. Wysowski United States	31	630 1.4×	331 0.9×	184 0.6×	354 1.3×	287 1.1×	49	3.8k
Annalisa Capuano Italy	41	1.1k 2.5×	566 1.5×	230 0.8×	547 2.1×	249 1.0×	266	5.8k
Geneviève Durrieu France	24	97 0.2×	396 1.1×	225 0.8×	320 1.2×	185 0.7×	105	1.7k
Marco Tuccori Italy	31	485 1.1×	212 0.6×	92 0.3×	132 0.5×	78 0.3×	110	2.7k

Countries citing papers authored by Janet Sultana

Since Specialization

Citations

This map shows the geographic impact of Janet Sultana's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Janet Sultana with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Janet Sultana more than expected).

Fields of papers citing papers by Janet Sultana

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Janet Sultana. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Janet Sultana. The network helps show where Janet Sultana may publish in the future.

Co-authorship network of co-authors of Janet Sultana

This figure shows the co-authorship network connecting the top 25 collaborators of Janet Sultana. A scholar is included among the top collaborators of Janet Sultana based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Janet Sultana. Janet Sultana is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sultana, Janet, et al.. (2025). The evolving therapeutic landscape of dementia with Lewy bodies. The Lancet Neurology. 24(12). 1038–1052.

Portelli, Stephanie, et al.. (2023). Prevalence of Opioid Use in Nursing Homes Over the Last Decade: A Systematic Literature Review. Journal of Pharmacy Technology. 40(3). 123–133. 1 indexed citations

Dogné, Jean‐Michel, Janet Sultana, Sabine M. J. M. Straus, et al.. (2023). An Exploratory Study of the Impact of COVID-19 Vaccine Spontaneous Reporting on Masking Signal Detection in EudraVigilance. Drug Safety. 46(11). 1089–1103. 9 indexed citations

Sultana, Janet, et al.. (2023). A scoping review of legibility of hand-written prescriptions and drug-orders: the writing on the wall. Expert Review of Clinical Pharmacology. 16(7). 617–621. 2 indexed citations

Borg, John-Joseph, et al.. (2023). Nivolumab Safety in Renal Cell Carcinoma: A Case Report. Journal of Pharmacy Technology. 40(2). 112–117.

Sultana, Janet, Maria Vadalà, Teresio Avitabile, et al.. (2022). Assessment of intravitreal anti-VEGF drugs and dexamethasone for retinal diseases in real world setting: A multi-centre prospective study from Southern Italy. European Journal of Ophthalmology. 32(5). 3064–3073. 3 indexed citations

Sultana, Janet, et al.. (2022). Identifying and categorizing compounds that reduce corneal transforming growth factor beta induced protein levels: a scoping review. Expert Review of Clinical Pharmacology. 15(12). 1423–1442. 2 indexed citations

Crisafulli, Salvatore, Nicoletta Luxi, Janet Sultana, et al.. (2021). Global epidemiology of acromegaly: a systematic review and meta-analysis. European Journal of Endocrinology. 185(2). 251–263. 53 indexed citations

Scerri, Josianne, et al.. (2021). Advocating a person-centered care approach to drug safety. Expert Opinion on Drug Safety. 20(3). 255–258. 4 indexed citations

10.

Crisafulli, Salvatore, et al.. (2021). Assessing intravitreal anti-VEGF drug safety using real-world data: methodological challenges in observational research. Expert Opinion on Drug Safety. 21(2). 205–214. 5 indexed citations

11.

Sultana, Janet, et al.. (2020). Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis. Orphanet Journal of Rare Diseases. 15(1). 141–141. 254 indexed citations breakdown →

12.

Sultana, Janet, et al.. (2020). Azithromycin in COVID-19 Patients: Pharmacological Mechanism, Clinical Evidence and Prescribing Guidelines. Drug Safety. 43(8). 691–698. 102 indexed citations

13.

Sultana, Janet, Giampiero Mazzaglia, Nicoletta Luxi, et al.. (2020). Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations. Expert Review of Vaccines. 19(10). 919–936. 68 indexed citations

14.

Sultana, Janet, Marcel de Wilde, Maria de Ridder, et al.. (2019). Identifying Data Elements to Measure Frailty in a Dutch Nationwide Electronic Medical Record Database for Use in Postmarketing Safety Evaluation: An Exploratory Study. Drug Safety. 42(6). 713–719. 4 indexed citations

15.

Sultana, Janet, Andrea Fontana, Francesco Giorgianni, et al.. (2019). Measuring the Effectiveness of Safety Warnings on the Risk of Stroke in Older Antipsychotic Users: A Nationwide Cohort Study in Two Large Electronic Medical Records Databases in the United Kingdom and Italy. Drug Safety. 42(12). 1471–1485. 9 indexed citations

16.

Sultana, Janet, Francesco Trotta, Antonio Addis, et al.. (2019). Healthcare Database Networks for Drug Regulatory Policies: International Workshop on the Canadian, US and Spanish Experience and Future Steps for Italy. Drug Safety. 43(1). 1–5. 12 indexed citations

17.

Sultana, Janet, Ugo Moretti, Antonio Addis, et al.. (2018). Workshop on the Italian Pharmacovigilance System in the International Context: Critical Issues and Perspectives. Drug Safety. 42(5). 683–687. 6 indexed citations

18.

Sultana, Janet, Andrea Fontana, Francesco Giorgianni, et al.. (2017). Can information on functional and cognitive status improve short-term mortality risk prediction among community-dwelling older people? A cohort study using a UK primary care database. Clinical Epidemiology. Volume 10. 31–39. 10 indexed citations

19.

Sultana, Janet, et al.. (2016). Antipsychotic use in dementia patients in a general practice setting: a Dutch population-based study. Epidemiology and Psychiatric Sciences. 25(4). 403–406. 1 indexed citations

20.

Trifirò, Gianluca, Janet Sultana, Francesco Giorgianni, et al.. (2014). Chronic Kidney Disease Requiring Healthcare Services: A New Approach to Evaluate Epidemiology of Renal Disease. BioMed Research International. 2014. 1–6. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact